KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) EBT Margin (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -913.00
Dec 31, 2025 1,153.00
Sep 30, 2025 -555.00
Jun 30, 2025 -237.00
Mar 31, 2025 2,747.00
Dec 31, 2024 -2,944.00
Sep 30, 2024 -43.00
Jun 30, 2024 58.00
Mar 31, 2024 578.00
Dec 31, 2023 -555.00
Sep 30, 2023 -480.00
Jun 30, 2023 1,494.00
Mar 31, 2023 -1,572.00
Dec 31, 2022 -1,010.00
Sep 30, 2022 2,159.00
Jun 30, 2022 -2,830.00
Mar 31, 2022 772.00
Dec 31, 2021 298.00
Sep 30, 2021 1,738.00
Jun 30, 2021 -2,139.00
Mar 31, 2021 4,060.00
Dec 31, 2020 -3,025.00
Sep 30, 2020 2,602.00
Jun 30, 2020 -4,259.00
Mar 31, 2020 63.00
Dec 31, 2019 1,172.00
Sep 30, 2019 1,382.00
Jun 30, 2019 -2,272.00
Mar 31, 2019 6,107.00
Dec 31, 2018 -6,210.00
Sep 30, 2018 922.00
Jun 30, 2018 -1,095.00
Mar 31, 2018 1,984.00
Dec 31, 2017 -1,453.00
Sep 30, 2017 -394.00
Jun 30, 2017 198.00
Mar 31, 2017 251.00
Dec 31, 2016 -191.00
Sep 30, 2016 -117.00
Jun 30, 2016 268.00
Mar 31, 2016 -25.00
Dec 31, 2015 235.00
Sep 30, 2015 -154,052.00
Jun 30, 2015 154,053.00
Mar 31, 2015 4,672.00
Dec 31, 2014 -3,271.00
Sep 30, 2014 -1,540.00
Jun 30, 2014 91.00
Mar 31, 2014 3.00
Dec 31, 2013 55.00
Sep 30, 2013 -155.00
Jun 30, 2013 54.00
Mar 31, 2013 -428.00
Dec 31, 2012 -268.00
Sep 30, 2012 438.00
Jun 30, 2012 710.00